Salix Pharma Posts Q1 Loss - Quick Facts

(RTTNews) - Salix Pharmaceuticals Ltd. (SLXP) Thursday reported first-quarter loss of $43.9 million or $0.69 per share, compared to a profit of $22.4 million or $0.35 per share in the same period last year.

Adjusted earnings for the quarter were $77.8 million or $1.05 per share. On average, 15 analysts polled by Thomson Reuters expected the company to earn $0.91 per share for the quarter. Analysts' estimates typically exclude special items.

Product revenues increased to $384.4 million from $202.6 million last year. Analysts expected revenues of $372.94 million.

Looking ahead to the second quarter, the company has forecast revenues of approximately $395.0 million. Analysts currently expect second-quarter revenues of $393.39 million.

For the fiscal 2014, the company currently projects revenues of approximately $1.6 billion. Analysts currently expect full-year revenues of $1.62 billion.